SK Chemicals announced the approval for its tetravalent vaccine with the cell cultivation system is drawing near
The SK Chemicals’ tetravalent influenza vaccine, having the cell cultivation system, is expected to acquire an approval soon.
On the 1st, Hoon Kim, Vaccine R&D Director of SK Chemicals, announced at the ‘Global Bio Conference 2015,’ held at Songdo Convensia, that it has turned in an approval to ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
